Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma

被引:48
作者
Guo, Xiaodong [1 ]
Yang, Mei [1 ]
Gu, Hao [2 ]
Zhao, Jingmin [1 ]
Zou, Lin [3 ]
机构
[1] PLA, Hosp 302, Beijing 100039, Peoples R China
[2] Xinjiang Med Univ, Dept Laparoscop Surg, Xinjiang 830054, Peoples R China
[3] PLA, Hosp 301, Beijing 100031, Peoples R China
关键词
Hepatocellular carcinoma; SOX6; Expression; Tumor progression; Prognosis; AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; PROLIFERATION; MUTATIONS; RESECTION; SURVIVAL; PROTEIN; MARKER;
D O I
10.1016/j.canep.2013.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and aim: SOX6, a member of the D subfamily of sex determining region y-related transcription factors, plays critical roles in cell fate determination, differentiation and proliferation. It has been identified as a tumor suppressor or an oncogene in different human cancers. However, the role of SOX6 in the development and progression of hepatocellular carcinoma (HCC) has not been explored. The aim of this study was to investigate the expression of SOX6 in HCC and determine its correlation with tumor progression and prognosis. Methods: 130 HCC patients who had undergone curative liver resection were selected and immunohistochemistry, Western blotting, and quantitative real time polymerase chain reaction (Q-PCR) were performed to analyze SOX6 expression in the respective tumors. Results: Q-PCR, immunohistochemistry and Western blotting consistently confirmed the decreased expression of SOX6 at both mRNA and protein levels in HCC tissues compared with their adjacent nonneoplastic tissues (P < 0.01). Additionally, the expression of SOX6, determined by immunohistochemistry, was negatively correlated with the tumor stage (P = 0.003) and serum AFP (P = 0.02). Moreover, HCC patients with lower SOX6 expression had worse 5-year disease-free survival and 5-year overall survival than those with high SOX6 expression (P = 0.006 and 0.001, respectively). Furthermore, the Cox proportional hazards model showed that the decreased expression of SOX6 was an independent poor prognostic factor for both 5-year disease-free survival (hazards ratio [HR] = 2.398, 95% confidence interval [CI] = 1.601-5.993, P = 0.01) and 5-year overall survival (HR = 3.569, CI = 1.381-7.290, P = 0.008) in HCC. Conclusion: These findings provide evidence for the first time that SOX6 expression was decreased in HCC, which correlated with poor prognosis, suggesting that SOX6 may be a novel and potential prognostic marker for HCC. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:732 / 736
页数:5
相关论文
共 32 条
[1]  
Abu El Makarem Mona, 2012, Hepat Mon, V12, pe6122
[2]   The SOX family of genes in cancer development: biological relevance and opportunities for therapy [J].
Castillo, Sandra D. ;
Sanchez-Cespedes, Montse .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (09) :903-919
[3]   Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients [J].
Chen, Chien-Hung ;
Hu, Fu-Chang ;
Huang, Guan-Tarn ;
Lee, Po-Huang ;
Tsang, Yuk-Ming ;
Cheng, Ann-Lii ;
Chen, Ding-Shinn ;
Wang, Jung-Der ;
Sheu, Jin-Chuan .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (09) :1630-1639
[4]   Association of Obesity-related Genetic Variants With Endometrial Cancer Risk: A Report From the Shanghai Endometrial Cancer Genetics Study [J].
Delahanty, Ryan J. ;
Beeghly-Fadiel, Alicia ;
Xiang, Yong-Bing ;
Long, Jirong ;
Cai, Qiuyin ;
Wen, Wanqing ;
Xu, Wang-Hong ;
Cai, Hui ;
He, Jing ;
Gao, Yu-Tang ;
Zheng, Wei ;
Shu, Xiao Ou .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (10) :1115-1126
[5]   Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis [J].
Dhir, Mashaal ;
Lyden, Elizabeth R. ;
Smith, Lynette M. ;
Are, Chandrakanth .
HPB, 2012, 14 (09) :635-645
[6]   Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development [J].
Dumitriu, Bogdan ;
Patrick, Michael R. ;
Petschek, Jane P. ;
Cherukuri, Srujana ;
Klingmuller, Ursula ;
Fox, Paul L. ;
Lefebvre, Veronique .
BLOOD, 2006, 108 (04) :1198-1207
[7]   Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD [J].
Durand, F ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2005, 42 :S100-S107
[8]   On the interpretation of x(2) from contingency tables, and the calculation of P [J].
Fisher, RA .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY, 1922, 85 :87-94
[9]   CAMPOMELIC DYSPLASIA AND AUTOSOMAL SEX REVERSAL CAUSED BY MUTATIONS IN AN SRY-RELATED GENE [J].
FOSTER, JW ;
DOMINGUEZSTEGLICH, MA ;
GUIOLI, S ;
KWOK, C ;
WELLER, PA ;
STEVANOVIC, M ;
WEISSENBACH, J ;
MANSOUR, S ;
YOUNG, ID ;
GOODFELLOW, PN ;
BROOK, JD ;
SCHAFER, AJ .
NATURE, 1994, 372 (6506) :525-530
[10]   Variable Selection in the Cox Regression Model with Covariates Missing at Random [J].
Garcia, Ramon I. ;
Ibrahim, Joseph G. ;
Zhu, Hongtu .
BIOMETRICS, 2010, 66 (01) :97-104